ChengDu, China

Muran Ding

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Systimmune, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Muran Ding. Retrieved from https://idiyas.com/inventor/muran-ding

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Muran Ding - Innovator in Antibody Development

Muran Ding is a prominent inventor based in ChengDu, China. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies. Her innovative work has led to the filing of a patent that showcases her expertise and dedication to advancing medical science.

Latest Patents

Muran Ding holds a patent for the Anti-trop2 Antibody. This invention represents a crucial step in the development of targeted therapies, which can potentially improve treatment outcomes for patients.

Career Highlights

Throughout her career, Muran has demonstrated a strong commitment to research and innovation. Her work at Systimmune, Inc. has positioned her as a key player in the biotechnology sector. She has been instrumental in driving forward projects that focus on antibody development and therapeutic applications.

Collaborations

Muran has collaborated with talented individuals such as Yi Zhu and Yong Zhang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Muran Ding's contributions to the field of biotechnology, particularly through her patent for the Anti-trop2 Antibody, highlight her role as an innovator. Her work at Systimmune, Inc. and collaborations with colleagues further emphasize her impact on advancing medical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…